TRAVELLI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 742
AS - Asia 552
EU - Europa 483
SA - Sud America 96
AF - Africa 12
OC - Oceania 3
Totale 1.888
Nazione #
US - Stati Uniti d'America 724
CN - Cina 176
SG - Singapore 172
HK - Hong Kong 127
IE - Irlanda 123
RU - Federazione Russa 108
BR - Brasile 80
DE - Germania 73
IT - Italia 72
FI - Finlandia 42
VN - Vietnam 32
GB - Regno Unito 23
BE - Belgio 9
CA - Canada 9
IN - India 9
JP - Giappone 8
ES - Italia 7
MX - Messico 7
AR - Argentina 6
BD - Bangladesh 6
AT - Austria 5
SA - Arabia Saudita 4
SE - Svezia 4
ZA - Sudafrica 4
FR - Francia 3
ID - Indonesia 3
IQ - Iraq 3
KR - Corea 3
LT - Lituania 3
MA - Marocco 3
NL - Olanda 3
PL - Polonia 3
AU - Australia 2
CO - Colombia 2
EC - Ecuador 2
EG - Egitto 2
PE - Perù 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.888
Città #
Hong Kong 127
Dublin 123
Chandler 113
Dallas 92
Ashburn 80
Beijing 73
Singapore 70
Boardman 41
Munich 40
Redondo Beach 30
Los Angeles 26
Helsinki 24
Shanghai 20
Moscow 19
The Dalles 18
Turku 18
Buffalo 17
New York 16
Ann Arbor 15
Falkenstein 15
Lawrence 15
Princeton 15
Ho Chi Minh City 14
Milan 13
Nuremberg 12
Medford 11
Chicago 10
São Paulo 10
Bolzaneto 9
Brussels 9
Wilmington 9
Guangzhou 7
Orem 7
Tokyo 7
Brooklyn 6
Hanoi 5
Mexico City 5
San Francisco 5
Bossico 4
Columbus 4
Council Bluffs 4
Norwalk 4
Novara 4
Rio de Janeiro 4
Rome 4
Santa Clara 4
Washington 4
Charlotte 3
Houston 3
Inverigo 3
Johannesburg 3
Londrina 3
Montreal 3
Richmond 3
Salvador 3
Seattle 3
Seoul 3
Shijiazhuang 3
Stockholm 3
Tianjin 3
Turin 3
Augusta 2
Barbianello 2
Barra Mansa 2
Bengaluru 2
Biên Hòa 2
Boston 2
Brasília 2
Des Moines 2
Duque de Caxias 2
Fortaleza 2
Genoa 2
Haiphong 2
Jakarta 2
Jeddah 2
Joinville 2
Kaifeng 2
Manchester 2
Miami 2
Mumbai 2
Pavia 2
Phoenix 2
Poplar 2
Raleigh 2
Toronto 2
Treviglio 2
Warsaw 2
'Asir Region 1
Abidjan 1
Adelaide 1
Andijan 1
Ankara 1
Anyang 1
Arona 1
Asyut 1
Atlanta 1
Auckland 1
Baghdad 1
Barueri 1
Biggar 1
Totale 1.289
Nome #
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 89
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 82
Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer 75
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 74
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 71
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents 67
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus 66
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 66
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 65
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 64
Molecular characterization of membrane steroid receptors in hormone-sensitive cancers 64
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 63
Molecular regulations of circadian rhythm and implications for physiology and diseases 61
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 60
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis 58
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 53
Disruption of epithelial barrier integrity via altered GILZ/c-Rel/RACK1 signaling in inflammatory bowel disease (IBD) 52
Prostaglandin E2 and cancer: Insight into tumor progression and immunity 52
Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis 49
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy 47
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer 44
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 42
NAMPT: A pleiotropic modulator of monocytes and macrophages 40
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 39
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 39
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 39
eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE Lung vasculitis and alveolar hemorrhage 37
Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy 35
Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies? 34
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 34
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 32
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 31
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 31
Characterization of NAD uptake in mammalian cells 30
NAD depletion by FK866 induces autophagy 30
Metabolic regulation of suppressive myeloid cells in cancer 29
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 28
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 27
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 25
Synthesis and Degradation of Adenosine 5′-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 24
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 24
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions 19
Totale 1.991
Categoria #
all - tutte 10.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 11 0 6 0 1 1
2021/202297 1 1 1 0 2 1 0 7 5 1 10 68
2022/2023317 17 34 15 22 22 34 0 18 143 2 8 2
2023/2024108 9 13 6 11 17 29 0 20 1 1 0 1
2024/2025710 38 45 10 49 2 48 62 30 155 18 111 142
2025/2026740 126 111 164 125 203 11 0 0 0 0 0 0
Totale 1.991